The US Capitol dome beside a desk calendar with a date circled in red and a hemp leaf silhouette, illustrating the federal hemp THC deadline

The Federal Hemp THC Deadline: A Live Tracker

August 13, 2026William Brink

Which date applies to what — read from the statute

The delay is one sentence long. Section 2019 of Public Law 119-103 says:

"Until December 11, 2026, the amendments made by section 781 of division B of Public Law 119-37 (7 U.S.C. 1639o note) shall only apply with respect to products described in paragraphs (1)(C)(ii)(I) and (1)(C)(iv)(I) of section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) (as amended by such section 781)."

That is the whole mechanism. Between 12 November and 11 December, the new hemp rules apply to two sub-paragraphs only. Everything else in section 781 waits until 11 December.

The two sub-paragraphs it names are the ones covering cannabinoids that, in the statute's words, "are not capable of being naturally produced by a Cannabis sativa L. plant." The amended definition lists a separate category right beside it: cannabinoids that "are capable of being naturally produced" but "were synthesized or manufactured outside the plant." Section 2019 does not name that second category. The Congressional Research Service, analysing the bill in report IF13136 (updated 17 August 2026, before enactment), described the split this way:

"On August 8, 2026, the Senate passed a continuing resolution (H.R. 6500) that would delay the effective date of most of the new hemp definition until December 11, 2026. Effective on November 12, 2026, would be the exclusion of intermediate and final hemp-derived cannabinoid products that contain cannabinoids that are not capable of being naturally produced by a cannabis plant (i.e., certain synthetic cannabinoids) from the definition of hemp."

Effective 12 November 2026, with no delay: products containing cannabinoids the plant is not capable of producing at all.
Delayed to 11 December 2026, on our reading: products containing cannabinoids the plant can produce but that were made outside it.
Also delayed to 11 December 2026: the limit of 0.4 mg combined total per container — covering total THC plus other cannabinoids the FDA is required to list as having similar effects, a list the FDA has never published — and the shift from a delta-9 standard to a total-THC standard that sweeps in THCA.

The distinction the statute draws is not synthetic versus natural. It is whether the plant could have made this molecule at all.

What that means for the products people actually buy

THC-O acetate loses hemp status on 12 November. It is an acetate ester the cannabis plant does not produce, and it is the clearest example of a cannabinoid "not capable of being naturally produced."

Delta-8 converted from CBD is where the argument is. Delta-8 THC occurs naturally in cannabis in small amounts. Commercial delta-8 is made by converting CBD in a lab, which on the face of the statute makes it a cannabinoid that was "synthesized or manufactured outside the plant" — the category section 2019 does not reach until 11 December. That is our reading, and it is shared by High Times, the National Agricultural Law Center, hemp attorney Rod Kight, and CRS's own framing of the delay as covering "most" of the definition. It is not the only reading. Bradley Arant, Akerman, Frier Levitt and Greenspoon Marder have all published the view that conversion-made delta-8, delta-10, HHC and THC-P lose hemp status on 12 November regardless; Bradley Arant puts it flatly: "None of the current delay proposals reach delta-8, delta-10, HHC, THC-O, or THCP made by chemical conversion — those lose hemp status on November 12 regardless of what happens with broader hemp reform." The Illinois Department of Agriculture's June 2026 bulletin names delta-8 alongside THC-O, HHC and THC-P as falling on 12 November. Foley Hoag, writing on 16 September, described the carve-out as "expressly limited" to cannabinoids "not capable of being naturally produced" — the structural point our reading rests on — but did not say where delta-8 lands.

So the honest position is this: the statute's structure favours 11 December for converted delta-8; a substantial body of practitioners says 12 November; and no federal agency has decided. Plan for 12 November. Treat 11 December as upside. There is a practical reason to do that quite apart from the federal question: Illinois (12 November), New Jersey (13–14 November, under its own beverage rules) and Virginia (1 November, under SB 543) all bite in November through state law, and a federal delay does not move any of them.

HHC we are not going to call. The DEA gave HHC its own drug code in a final rule on 4 May 2026 and describes it as "a synthetic substance that is structurally related to tetrahydrocannabinols." But the DEA was answering a different question under a different law, two federal appeals courts are being asked to review that listing, and no court has ruled on whether HHC occurs naturally. Which side of the hemp line it falls on is unsettled.

One distinction that catches almost everybody

Being inside the delay is not the same as being federally legal. The law we have been describing is the Agricultural Marketing Act definition — it decides whether something counts as hemp. The Controlled Substances Act is a separate statute that decides whether something is scheduled, and the DEA has said for years that THC made by chemical conversion was never lawful hemp THC to begin with. Its May 2026 rule repeats the point: cannabinoids "produced through chemical conversion, even when hemp derived[,] are considered synthetically produced for purposes of the CSA."

So a converted delta-8 product can sit inside the 11 December extension and still be something the DEA asserts is already a controlled substance. Those positions are being litigated. Anyone who tells you delta-8 is simply "legal until 11 December" is describing one of the two statutes and ignoring the other.

Why nobody can be certain about the edge cases yet

Section 781 required the FDA to publish three lists and one piece of guidance by 10 February 2026: cannabinoids the cannabis plant can naturally produce; naturally occurring THC-class cannabinoids; other known cannabinoids with similar effects; and a definition of "container" for the milligram limit. All four are still unpublished, more than seven months late. The Congressional Research Service noted the failure in August 2026.

FDA has issued no 2026 Federal Register rulemaking directed at cannabinoids. Its only 2026 Federal Register discussion of delta-8 THC appears as a supporting example in the preamble to a proposed rule about something else — the 11 August 2026 GRAS proposed rule, Docket FDA-2025-N-3262 — and FDA's own cannabis page is still marked content-current as of July 2024. The comment period on that GRAS proposal closes on 9 December 2026, two days before the hemp deadline.

Those lists are what would settle HHC and, in practice, the delta-8 argument. Until they exist there is no federal categorisation of delta-8, delta-10, HHC or THC-O under the new definition — the restrictions take effect regardless; the missing lists determine only how far past total THC the exclusions reach. Every confident answer about those four, including ours, is a reading of the statute rather than the government's own determination. We will update this section the moment the FDA publishes any of them.

For the full category-by-category walk-through — including both sides of the delta-8 argument, the HHC question and why the DEA's position is a separate fight — see Which cannabinoids actually lose hemp status on 12 November 2026?

What the law actually says

The provision is Section 781 of Division B of Public Law 119-37 — the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 — signed 12 November 2025. It changes two things.

First, the measurement. Federal hemp has always been capped at 0.3% THC by dry weight. The old text measured delta-9 THC specifically. The new text measures total THC, and it explicitly counts THCA and delta-8 THC toward that total.

That single word does most of the work. THCA flower has always been sold on the argument that raw, uncombusted flower is under 0.3% delta-9 THC even when it is 20–25% THCA. Counting THCA closes that argument completely.

Second, a hard milligram cap. Finished consumer products are limited to 0.4 mg of total THC per container. Not per serving — per container.

Law firm analyses of the provision estimate that roughly 95% of hemp cannabinoid products currently on the market fall outside the new definition. That figure is an estimate, not a government finding, but the direction is not in dispute.

The 0.4 mg math, on real products

The per-container cap is the part people misread most often, so here it is applied to formats we actually review.

Typical product	Total THC per container	Against a 0.4 mg cap
10 mg delta-9 gummy, 30-count jar	300 mg	750× over
25 mg delta-8 gummy, 20-count bag	500 mg	1,250× over
5 mg THC seltzer, single can	5 mg	12.5× over
3.5 g THCA flower at 22% THCA	roughly 675 mg total THC	far over, and fails the 0.3% test too
1 g delta-8 vape cartridge	roughly 900 mg	far over
Full-spectrum CBD tincture, 30 mL	commonly 15–45 mg	over, in most formulations
Broad-spectrum or isolate CBD	non-detect to trace	compliant
CBD topical, isolate-based	non-detect	compliant

Read that table again and notice what survives: CBD isolate and broad-spectrum CBD. Almost nothing else does. A single 5 mg seltzer — the mildest intoxicating hemp product on the market, roughly a third of a standard dispensary dose — is still more than twelve times the federal limit.

This is why "the hemp ban" is a reasonable shorthand even though the word "ban" appears nowhere in the statute. A 0.4 mg per-container cap is not a restriction on intoxicating hemp products. It is the end of them as a federally lawful category.

What has happened since

12 November 2025. Public Law 119-37 signed. One-year delay written in. Effective date set at 12 November 2026.

Through early 2026. Multiple bills introduced to delay, amend, or repeal the provision. None passed.

8 August 2026 — the Senate passes it, and rejects an attempt to cancel the delay. The Senate passed H.R. 6500 by 90 votes to 6 (roll call 228). Shortly before, at 2:36 in the morning, it turned back an amendment from Senator Ted Budd (R-N.C.) — S.Amdt. 6747 — whose stated purpose was "To strike section 2019," the section containing the delay. Striking it would have kept the hemp rewrite on its original 12 November date. Senator Amy Klobuchar (D-Minn.) moved to table the amendment, and the motion carried 61 to 32 (roll call 227), with 21 Republicans voting against tabling. Senator Budd said afterwards that he was "disappointed that the Senate chose to protect an industry that insists on selling dangerous intoxicants marketed toward children by delaying the hemp loophole." The Senate, in other words, considered killing the delay by name and declined.

1 September 2026 — the House passes it, 370–48. The House took up the bill under suspension of the rules, a procedure that bars amendments and requires a two-thirds majority, and passed it 370 to 48 (roll call 286). Because the House concurred in the Senate's amendments rather than writing its own, the measure went directly to the President. Representative Andy Harris (R-Md.), who chairs the appropriations subcommittee that funds FDA, led the objections, and a bipartisan coalition of 35 state and territory attorneys general had written urging Congress not to reverse the restrictions.

2 September 2026 — signed into law. H.R. 6500 became Public Law 119-103. The same law funds the federal government only through 11 December 2026 — the day the hemp provisions now take effect. That is not a coincidence, and it is worth planning around: the hemp deadline will arrive in the middle of the next government funding negotiation, and the people who moved it once will be in the room.

16 September 2026 — the farm bill advances, with no hemp language in the version anyone had read. The Senate Agriculture Committee advanced its 2026 farm bill 12–11 at a session closed to amendments. No hemp language appears in the version of the bill that had been published at that point. CRS's comparison of the House and Senate bills states that "Only in H.R. 7567 would the domestic hemp production program be amended" to reflect the new definition — but CRS was comparing the discussion draft released on 23 June 2026, not the text the committee reported, and we have not been able to sweep the reported text ourselves. See the 24 September entry below. Floor amendments are the one remaining route for hemp language on that vehicle, and the bill needs 60 votes. Trade coverage in mid-September expected the Senate to leave for roughly six weeks before the 3 November elections; that is not what the schedules show, and we have corrected it in the entry below. The wider point stands either way: the closer this runs to November, the more likely any legislative fix has to ride a lame-duck deal negotiated in the same window as the 11 December cliff.

24 September 2026 — the Senate farm bill gets a number, and a place in the queue. Chairman Boozman reported the bill out as S. 5526, the Agricultural Act of 2026. GovInfo's record of the action reads "Mr. Boozman, from the Committee on Agriculture, Nutrition, and Forestry, reported the following original bill; which was read twice and placed on the calendar," and the text itself opens "Calendar No. 683." Being placed on the calendar makes a bill eligible for floor consideration, not scheduled for it. The current farm bill extension expires 30 September. We read both Senate-side floor schedules on 26 September: the Senate sat on 22, 23 and 24 September, it convenes again at 3:00 p.m. on Monday 28 September, and neither schedule prints a farm bill item. We could not sweep the reported text for hemp language — it runs to 1.4 MB and our copy truncates inside Title II, well before the Title X horticulture provisions where hemp would sit. We set out what we verified and what we could not here.

27 September 2026 — the Senate's own calendar says it leaves on 5 October, and is due in Washington on 11 December. We read the Senate's Tentative 2026 Legislative Schedule for the first time today. It prints "Oct 05 - Nov 06 | State Work Period | Columbus Day - Oct 12"; then "Nov 11 - Nov 13" with no State Work Period label and Veterans Day noted; then "Nov 23 - Nov 27" and "Dec 21 - Dec 31" as State Work Periods. Three things follow, at exactly the confidence the page supports. First, it prints no State Work Period between 21 September and 5 October, so the week in which the farm bill extension expires is a working week on this schedule — a third independent Senate-side primary agreeing with the correction we made yesterday. Second, it gives 5 October as the date the pre-election absence is scheduled to begin, running through 6 November and spanning the 3 November elections. Third, 11 December falls inside no State Work Period on it: the December period begins on the 21st, ten days after the hemp carve-in lapses and government funding runs out. Two limits, both off the page itself — it is headed "Tentative", and it prints no legend, so what a blank State Work Period column means is not stated anywhere on it. The Senate floor schedule, re-read today, still shows Monday 28 September at 3:00 p.m. and no farm bill item.

S. 5526 was reported without a written committee report. The bill's legislative status record, read today, lists exactly three actions, all dated 24 September: "Placed on Senate Legislative Calendar under General Orders. Calendar No. 683." and, twice and identically, "Committee on Agriculture, Nutrition, and Forestry. Original measure reported to Senate by Senator Boozman. Without written report." There is therefore no committee report language on hemp, because there is no committee report at all — a verified negative about the report, which is not the same thing as one about the bill text. As of that record's 26 September timestamp it also carries no cosponsors, no legislative subject terms and no summaries, so the Congressional Research Service has not yet processed it. Title X remains unread. The Senate already voted on this delay by name, and kept it 61-32.

The Senate's own calendar targets adjournment on 18 December — a week after the cliff. We pulled the Senate's 2026 calendar PDF today, a separate rendering from the HTML tentative schedule we read yesterday. It is headed "UNITED STATES SENATE / 119th Congress, 2nd Session / 2026 / TENTATIVE SCHEDULE" and prints two fixed points: "2ND SESSION CONVENES - JANUARY 5, 2026" and "TARGET ADJOURNMENT - DECEMBER 18, 2026". That target is seven days after 11 December — the date section 2019 stops narrowing the ban and the date funding runs out — and 81 days from today. It is consistent with yesterday's reading of the HTML schedule, which prints no State Work Period covering 11 December. Two limits travel with it: the document calls itself tentative, and a target adjournment date is a target, not a floor calendar. The PDF does carry the legend the HTML page lacks — "Red days = Senate not in session" — but we could not recover the colour of any individual day from a text extraction, so we still cannot say what the blank State Work Period column on 11–13 November means.

A third hemp bill, filed in January and never moved: H.R. 7212. The Hemp Enforcement, Modernization, and Protection Act was introduced on 22 January 2026 by Rep. H. Morgan Griffith, R-Va., with Rep. Marc Veasey, D-Tex., as original cosponsor. Its official title is "To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes," and its status record — read today and boundary-checked — lists three actions, every one dated 22 January 2026, with no hearing or markup among them. It was referred to House Energy and Commerce rather than Agriculture and its policy area is Health, which is why it has stayed outside the farm bill coverage. Seven cosponsors, four Republicans and four Democrats counting the sponsor; Rep. James Baird appears on this bill, on H.R. 7010 and on H.R. 9830. We have not read the operative text — two GovInfo renderings returned a permission error today, so what the bill would do is reported here only as a named law firm describes it. What H.R. 7212 would do, and why it has not moved.

Two more bills that would change the outcome, and where they sit. H.R. 7010 (Rep. James Baird, R-Ind., introduced 12 January 2026 with four cosponsors including Rep. Angie Craig, D-Minn.) would replace section 781's "365 days" with "3 years." It was referred to the House Agriculture Committee and, on 20 May, to its Forestry and Horticulture subcommittee, where it sits. H.R. 9830, the Lawful Hemp Protection Act (Rep. Andy Barr, R-Ky., introduced 22 July 2026 with seven cosponsors — Craig again among them), would repeal section 781 and replace the definition with a regulated framework; we go through what it would and would not do, including why it would not save THCA flower, in our explainer. It was referred to four committees on the day it was introduced and none has acted on it since. Neither bill has had a hearing.

A 30-day delay is not a reprieve

It is worth being blunt about this, because a lot of coverage has not been. Moving the date from 12 November to 11 December changes when the rule bites. It does not change the rule. The 0.3% total-THC standard and the 0.4 mg per-container cap are identical in both versions.

The realistic outcomes, as of today, are: the 11 December date holds; it moves again inside the December funding bill, which must pass by the same day; or Congress passes something substantive that amends the standard itself. Only the third changes the destination, and none of the three standalone bills that would do it has had a hearing. Note that even the regulator enforcing the December date does not treat it as certain — Rhode Island's bulletin hedges the date, the limit and the penalty, each "subject to further guidance from the federal government."

The state layer sits on top of this

Federal law sets a floor, not a ceiling. States have always been free to be stricter, and many already are — several banned delta-8 years before Congress acted, and a handful restrict hemp THC more tightly than the new federal standard will.

Two practical consequences. First, a product that is federally compliant can still be illegal where you live. Second, in states with their own hemp licensing regimes, the state rule may govern your purchase regardless of what happens in Washington. Tennessee, for example, moved its hemp products under TABC licensing effective 1 July 2026, with standards that do not mirror the federal text.

We are building a state-by-state breakdown as a companion to this page. Until it is up, check your own state's agriculture or ABC agency directly rather than relying on a retailer's shipping map — those maps track where a brand is willing to ship, which is not the same question as what is legal where you are.

What state regulators are actually telling licensees about the federal date

Very few have said anything. As of 20 September we can find exactly two state regulators that have put the 11 December date in a dated instrument, and the split between the rest tracks how old each document is, not where the state sits.

Rhode Island — Cannabis Control Commission Bulletin 2026-7, issued 11 September 2026: hemp-derived products "shall not contain more than 0.4mgs of total THC per container, subject to further guidance from the federal government," and all products over that limit "must be removed from licensed facilities prior to December 11, 2026." The bulletin also closes an escape route most states are silent on: over-limit products "shall not be permitted to be transferred to a licensed cannabis retailer" and "will not be permitted to be sold as cannabis products." And it treats a website as a point of sale — over-limit products may not be "shown, displayed or advertised on any website." It says nothing about delta-8, conversion or synthesis.
Minnesota — Office of Cannabis Management hemp FAQ, revised 4 September 2026: the federal prohibition "becomes effective Dec. 11, 2026." Silent on every cannabinoid by name.
Illinois — Department of Agriculture bulletin IB-2026-06, dated June 2026: "On November 12, 2026, the Industrial Hemp Act will be repealed and replaced," adopting the federal definition "set to take effect on November 12." Names delta-8, THC-O, HHC and THC-P. Written before the delay existed and not revised since.
New York — Office of Cannabis Management FAQ, last updated November 2025: the law "has a one year delayed effective date (November 2026)." A month and a year, no day. Not revised for the September law.
New Jersey — Cannabis Regulatory Commission FAQ, revised 16 April 2026: states no federal date at all. Every date in it is a New Jersey statutory date, including 13 and 14 November for hemp beverages.

The pattern is document age. Anything touched in September says December; anything written before the delay says November or nothing. If your state has not revised its guidance since 2 September, it has not caught up, and you should not read its November date as a considered position on the federal split.

What this means if you buy hemp products

Nothing has changed yet. Every product legal to buy on 13 August 2026 is still legal to buy today. The change is prospective.

Watch December. The next real decision point is the government funding bill that has to pass by 11 December — the same day most of the hemp rules take effect. That bill is the obvious vehicle for moving the date again, in either direction, and it will be negotiated during a lame-duck session after the 3 November elections.

Be sceptical of deadline marketing. Expect "last chance before the ban" promotions to escalate through the autumn. Some will be honest. Some will be selling old inventory at full price against a date that has already moved. A discount is only a good deal if the product was worth buying at the undiscounted price.

Stocking up has real limits. Gummies and tinctures degrade — we covered the actual timelines in our shelf life and storage guide. Buying two years of product to beat a deadline means consuming a good portion of it past its best. And if your state moves independently, a legal purchase today can become an illegal possession later. That is a question for a lawyer in your state, not for a review site.

CBD is largely unaffected. If you use isolate or broad-spectrum CBD products, the new definition does not touch them. Full-spectrum is the exception — that is where the residual THC lives, and it is where the per-container cap will be felt. Our guide to full-spectrum vs broad-spectrum vs isolate explains which is which.

How we maintain this page

We check the status of this provision weekly and update this page when something actually changes — a floor vote, a signature, an agency rule, a material state action. We do not update it for speculation, press releases, or advocacy statements. Every change is logged below with a date.

If you find something here that is out of date or wrong, tell us through our contact page and we will correct it and log the correction.

Changelog

28 September 2026 — Added the Senate's 2026 calendar PDF, which prints "TARGET ADJOURNMENT - DECEMBER 18, 2026", seven days after the 11 December cliff, and which carries the legend the HTML tentative schedule lacks. Added H.R. 7212, the Hemp Enforcement, Modernization, and Protection Act, a regulation bill referred to House Energy and Commerce on 22 January 2026 whose status record shows no action since that day. Re-read the Senate floor schedule: unchanged for a fifth consecutive day, with no farm bill item two days before the extension lapses. H.R. 7212's operative text and Title X of S. 5526 both remain unread and are flagged as such.
27 September 2026 — Added the Senate's Tentative 2026 Legislative Schedule, which prints a State Work Period from 5 October to 6 November and none covering 11 December. This supplies the departure date that yesterday's correction left open: we now have a scheduled start for the pre-election absence rather than a trade outlet's forecast of one. Added that S. 5526 was reported without a written committee report, so there is no report language on hemp to read. Added a link to our breakdown of the 61-32 vote that kept section 2019 in the bill. Title X of the reported farm bill text is still unread and still flagged as such.
26 September 2026 — Added S. 5526: the Senate farm bill was reported on 24 September and placed on the Senate calendar as Calendar No. 683. Corrected two statements on this page. First, we had written that the Senate leaves for roughly six weeks before the 3 November elections; both Senate-side floor schedules, read on 26 September, show the Senate sitting on 22, 23 and 24 September and returning at 3:00 p.m. on 28 September, so that line was wrong and has been replaced with what the schedules print. Second, we had written flatly that the Senate farm bill contains no hemp language; the sources for that statement describe the June discussion draft and the pre-markup proposal rather than the reported bill, and we have not been able to sweep the reported text, so the claim is now scoped to what was actually read.
20 September 2026 — H.R. 6500 became Public Law 119-103 on 2 September 2026; most of the hemp rewrite now takes effect 11 December 2026 rather than 12 November. Corrected the Senate vote (90–6 on 8 August, not 89–4 on 3 August). Corrected our previous statement that products containing "synthetic cannabinoids" would lose hemp status on 12 November regardless — the statute delays a category of cannabinoids the plant can produce but that were made outside it, and whether converted delta-8 falls inside that category is contested; we now show both readings and say which is ours. Added the statutory text, the Senate roll call on the Budd amendment, the DEA's separate Controlled Substances Act position, the FDA's overdue lists, the state regulator table, the farm bill and the two pending House bills.
14 August 2026 — Page published. Status: 12 November 2026 effective date stands; Senate stopgap proposing 11 December passed the Senate, awaiting House action in September. (Corrected 20 September: this entry originally recorded the Senate vote as 89–4 on 3 August; the vote was 90–6 on 8 August, roll call 228.)

Frequently Asked Questions

Is THCA flower illegal now?

No. As of 28 September 2026 nothing has changed in federal law yet. Under the new definition — now taking effect 11 December 2026 for the total-THC standard, under Public Law 119-103 — THCA counts toward the 0.3% total THC limit, which would remove essentially all THCA flower from the federal hemp category. State law may already restrict it where you live.

Does the 0.4 mg limit apply per serving or per package?

Per container. A 30-count jar of 10 mg gummies contains 300 mg of total THC in one container, which is 750 times the cap. The per-container framing is what makes the provision so sweeping.

Will CBD still be legal?

CBD isolate and broad-spectrum CBD products contain negligible THC and remain within the new definition. Full-spectrum products are the ones at risk, because they carry residual THC that frequently exceeds 0.4 mg per container.

Could the deadline change again?

Yes. It has already moved once, in a law that also funds the government only until the same day, so the next funding bill is the obvious vehicle for moving it again — in either direction. Three standalone bills would change it more substantially and none has had a hearing. We update this page when the status actually changes rather than when a delay is proposed.

What happens to products already in my possession?

The provision addresses what qualifies as federal hemp, which governs production and interstate commerce. Personal possession is primarily a matter of state law, and it varies. If that is your specific concern, ask a lawyer licensed in your state.